FDA inspection
Shire Human Genetic Therapies, Inc.: FDA inspection ending Jan 5, 2017
FDA inspection 1002403 · No Action Indicated (NAI) · North Reading, MA
Key facts
| Inspection ID | 1002403 |
|---|---|
| Firm | Shire Human Genetic Therapies, Inc. |
| FEI number | 3008424653 |
| Address | 200 Riverpark Dr |
| City | North Reading |
| State | MA |
| ZIP | 01864 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Jan 5, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data